Preadmission Statin Use and 90-day Mortality in the Critically Ill A Retrospective Association Study

Conclusions Preadmission statin use was associated with a lower 90-day mortality. This association was more evident in the rosuvastatin group and with noncardiovascular 90-day mortality; no differences were seen according to daily dosage intensity.

Source: Anesthesiology - July 17, 2019 Category: Anesthesiology Source Type: research